Table 2 Receiver operating characteristic analysis: area under the curves and optimal cut-off values.

From: A Pilot Study of 18F-Alfatide PET/CT Imaging for Detecting Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer

Parameter

NSCLC

AC

SCC

AUC(95%CI)

Cut-off value

P

AUC(95%CI)

Cut-off Value

P

AUC(95%CI)

Cut-off Value

P

SUVmax

0.95(0.91–0.98)

>1.4

0.002

0.86(0.78–0.92)

>1.4

0.02

0.98(0.91–1.0)

>1.3

0.14

SUVmean

0.94(0.90–0.97)

>1.2

0.008

0.83(0.75–0.90)

>1.1

0.05

0.97(0.89–1.0)

>1

0.29

SUVLN/PT

0.89(0.83–0.93)

>0.3

 

0.71(0.61–0.79)

>0.3

 

0.95(0.86–0.99)

>0.3

 

SUVLN/MBP

0.92(0.87–0.96)

>1.5

0.24

0.82(0.73–0.89)

>0.9

0.40

0.98(0.91–1.0)

>1.5

0.14

SUVLN/M

0.97(0.94–0.99)

>2.4

0.01

0.94(0.88–0.98)

>2.4

0.06

0.98(0.91–1.0)

>2.6

0.14

  1. CI, confidence interval; SUV, standardized uptake value; LN, lymph node; MBPS, mediastinal blood pool; PT, primary tumor; M, muscle; P, P value.